PAR paradigm biopharmaceuticals limited..

Where are we on a deal?, page-8

  1. 601 Posts.
    lightbulb Created with Sketch. 150
    I re-listened to sharewise interview. Paul states the companies biggest risk, once the IND phase 3 acceptance goes through is……….. not financial ruin/risk, but execution risk.

    A partner is signed in non binding….. surely. We sit and wait
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.8¢
Change
-0.013(3.79%)
Mkt cap ! $128.1M
Open High Low Value Volume
32.5¢ 33.5¢ 31.8¢ $221.5K 687.4K

Buyers (Bids)

No. Vol. Price($)
12 37515 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 36478 5
View Market Depth
Last trade - 11.16am 07/08/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.